Equities
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)6,966.00
  • Today's Change-185.00 / -2.59%
  • Shares traded210.90k
  • 1 Year change+1.19%
  • Beta0.9974
Data delayed at least 15 minutes, as of Jul 01 2025 01:47 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Otsuka Holdings Co Ltd is a Japan-based company mainly engaged in medical, nutraceutical, consumer and other business activities in Japan and overseas. The Company operates in four business segments. The Medical Business segment produces and sells therapeutic drugs and infusions. The Nutraceutical segment produces and sells functional beverages, quasi-drugs and nutritional supplements. The Consumer Products segment produces and sells mineral water, beverages and food products. The Others segment manufactures paper containers, manufactures synthetic resin molded products, stores products, provides storage space, and produces and sells chemicals and liquid crystal evaluation equipment, spectroscopic analysis equipment, and other products.

  • Revenue in JPY (TTM)2.39tn
  • Net income in JPY350.74bn
  • Incorporated2008
  • Employees35.34k
  • Location
    Otsuka Holdings Co LtdShinagawa Grand Central Tower2-16-4, KonanMINATO-KU 108-8241JapanJPN
  • Phone+81 367171410
  • Fax+81 367171409
  • Websitehttps://www.otsuka.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ono Pharmaceutical Co Ltd486.87bn50.05bn770.48bn4.29k14.500.927610.001.58106.52106.521,036.361,665.600.49242.403.79113,569,200.005.0710.785.8512.3769.6173.2310.3021.232.56142.590.156936.33-3.1410.73-60.89-3.47-18.6612.20
Eisai Co Ltd789.40bn46.43bn1.19tn13.51k24.891.3713.521.51163.81163.812,784.172,982.520.56780.86444.4758,448,100.003.463.814.685.1478.6277.466.096.441.37--0.17898.016.422.569.49-17.54-14.480.00
Kyowa Kirin Co Ltd494.71bn51.40bn1.28tn5.67k25.111.5416.752.6097.3497.34939.971,588.590.47451.783.9287,266,360.004.936.375.757.2573.4075.1310.3914.652.7117.520.0046.3812.0610.14-26.269.7137.716.67
Shionogi & Co Ltd438.27bn170.44bn2.25tn4.96k12.651.5811.845.14200.28200.28514.991,600.970.29690.9793.6188,449,650.0011.4912.1712.6913.7485.4484.9138.6838.306.13--0.015827.870.73255.625.196.8834.6612.30
Astellas Pharma Inc1.91tn50.75bn2.54tn13.64k50.881.6610.151.3327.5627.561,062.16845.250.55361.283.28140,168,800.001.473.052.224.4581.7481.152.655.420.85164.000.3824131.4219.258.01197.72-23.64-5.9413.09
Otsuka Holdings Co Ltd2.39tn350.74bn3.85tn35.34k10.891.428.301.61650.78650.784,433.965,000.590.67012.295.0367,722,650.009.925.9112.387.2772.2069.1814.819.891.44--0.085932.9315.4210.78182.1321.9615.323.71
Daiichi Sankyo Co Ltd1.89tn295.76bn6.25tn19.77k21.153.7917.153.31155.87155.87994.10869.690.54540.87264.2495,434,150.008.555.7210.877.1177.9672.1515.6811.031.85--0.087649.5717.7713.9544.4717.7729.0120.79
Takeda Pharmaceutical Co Ltd4.58tn107.93bn6.95tn47.46k65.330.99077.991.5266.8366.832,880.434,407.010.31211.307.2596,545,170.000.73671.710.88152.0465.5167.662.365.990.52022.520.3943123.757.456.84-25.0819.539.821.72
Chugai Pharmaceutical Co Ltd1.22tn410.15bn12.62tn7.78k30.156.48--10.32249.23249.23742.641,158.970.60541.394.57157,125,400.0020.3219.5522.8523.9571.0165.5133.5630.126.16--0.0039.665.3311.2719.0019.71-2.1416.00
Data as of Jul 01 2025. Currency figures normalised to Otsuka Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

21.23%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 13 Sep 202426.28m4.76%
The Vanguard Group, Inc.as of 04 Jun 202515.78m2.86%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 13 Jun 202514.31m2.59%
Nikko Asset Management Co., Ltd.as of 13 Jun 202513.03m2.36%
Daiwa Asset Management Co. Ltd.as of 30 May 202511.76m2.13%
BlackRock Fund Advisorsas of 05 Jun 202510.20m1.85%
Wellington Management Co. LLPas of 30 May 20257.48m1.36%
Norges Bank Investment Managementas of 31 Dec 20246.60m1.20%
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Jun 20256.57m1.19%
Geode Capital Management LLCas of 26 Jun 20255.17m0.94%
More ▼
Data from 31 Dec 2024 - 26 Jun 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.